series-c-plus
Stage
1
Investors
About
Nanolive develops automated label-free live cell imaging and analysis technology that enables noninvasive, high-content monitoring of cellular dynamics using AI-powered digital assays.
Explore Nanolive's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.